Search Results - "Dotti, A Z"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    P586 Vedolizumab in Mild to Moderate Crohn’s Disease Patients Naïve to Biological Therapy: a Multicentric Observational Study

    P586 Vedolizumab in Mild to Moderate Crohn’s Disease Patients Naïve to Biological Therapy: a Multicentric Observational Study by Dotti, A Z, Vilela, E G, Chebli, J M F, Chebli, L A, Magro, D O, Steinwurz, F, Argollo, M, Carvalho, N S, Parente, J M L, Parra, R S, Perin, R L, Flores, C, Morsoletto, E M, Ferreira, S D C, Ludvig, J C, Kaiser Jr, R L, Queiroz, N S F, Faria, M A G, Nicollelli, G M, Andrade, A R, Kotze, P G

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background Vedolizumab, a human monoclonal antibody that blocks integrin α4-β7, was approved for the management of Inflammatory Bowel Diseases. In…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Incidence and risk factors for sepsis in surgical patients: a cohort study

    Incidence and risk factors for sepsis in surgical patients: a cohort study by Georgeto, AAFS, Elias, ACGP, Tanita, MT, Grion, CMC, Cardoso, LTQ, Verri, P, Veiga, CFF, Barbosa, ÁRG, Dotti, AZ, Matsuo, T

    Published in Critical care (London, England) (01-01-2011)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: